Additionally, EZY-1 inhibited the phosphorylation of ERK and p38MAPK, blocking IPF progression through inhibition of the TGF-β-activated MAPK signaling pathway. This evidence concerns the gene TGFB1 and idiopathic pulmonary fibrosis.